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Abstract: Advanced additive manufacturing techniques such as electron beam melting 
(EBM), can produce highly porous structures that resemble the mechanical properties and 
structure of native bone. However, for orthopaedic applications, such as joint prostheses or 
bone substitution, the surface must also be bio-functionalized to promote bone growth.  
In the current work, EBM porous Ti6Al4V alloy was exposed to an alkali acid heat (AlAcH) 
treatment to bio-functionalize the surface of the porous structure. Various molar 
concentrations (3, 5, 10M) and immersion times (6, 24 h) of the alkali treatment were used 
to determine optimal parameters. The apatite forming ability of the samples was evaluated 
using simulated body fluid (SBF) immersion testing. The micro-topography and surface 
chemistry of AlAcH treated samples were evaluated before and after SBF testing using 
scanning electron microscopy and energy dispersive X-ray spectroscopy. The AlAcH 
treatment successfully modified the topographical and chemical characteristics of EBM 
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porous titanium surface creating nano-topographical features ranging from 200–300 nm in 
size with a titania layer ideal for apatite formation. After 1 and 3 week immersion in SBF, 
there was no Ca or P present on the surface of as manufactured porous titanium while both 
elements were present on all AlAcH treated samples except those exposed to 3M, 6 h alkali 
treatment. An increase in molar concentration and/or immersion time of alkali treatment 
resulted in an increase in the number of nano-topographical features per unit area as well as 
the amount of titania on the surface. 
Keywords: porous titanium; chemical surface treatment; apatite formation; additive 
manufacturing 
 
1. Introduction 
Titanium has long been used for biomedical applications because of its combined superiority in 
biocompatibility, mechanical properties and corrosion resistance [1–3]. However, orthopaedic implants 
fabricated of solid titanium and its alloys have been shown to lack in performance due to the stress 
shielding effect, subsequently causing implant loosening [4,5]. Although titanium has a lower Young’s 
modulus than alternative biomaterials (i.e., stainless steel or cobalt-chrome), stress shielding continues 
to exist causing bone resorption due to the difference in stiffness between the titanium implant (110 GPa 
for alloy Ti6Al4V) and adjacent bone (20–30 GPa for cortical bone) eventually initiating implant 
loosening [6]. Porous titanium was thus developed with an aim to improve implant performance by 
reducing the difference in stiffness between the interacting implant and adjacent bone through the 
addition of pores, in some cases achieving implant stiffness between 3.5–25 GPa [6–8]. Ideally the 
porous titanium is to mimic native bone structure and stiffness to eradicate bone resorption. Furthermore, 
porous titanium has also improved implant performance by increasing surface area and porosity allowing 
higher levels of bone ingrowth [9,10] and the incorporation of functional molecules [11]. Over the past 
decade, porous titanium has thus emerged as a breakthrough material showing potential by minimizing 
stress shielding effects, improving bone ingrowth and creating larger surface areas for drug delivery 
media, particularly in orthopaedics for joint prosthesis [12–15] or bone substitution [16–19].  
New ways to manufacture porous titanium are constantly being developed with an aim to achieve 
similar porous structure and mechanical properties as native bone. As a result, the porous structure will 
allow for bone ingrowth and incorporation of functional molecules while the mechanical properties are 
important in avoiding stress shielding effects. Various manufacturing methods such as gel casting [6], 
loose powder sintering [7], powder metallurgy space holder and titanium fibre sintering [8] have been 
successfully developed. Yang et al. [6] demonstrated that with gel casting methodologies porosities 
between ~38%–58% resulted in specific Young’s moduli between 7–25 GPa, fitting within the range of 
native cortical bone stiffness. In a comparison study between sintering and space holder methodologies, 
loose powder sintering formed an interconnected structure with ~42% porosity with specific Young’s 
moduli of 20–25 GPa however the space holder technique dominated as the size of pores and porosity 
were controllable achieving better mechanical properties [7]. A porosity between 50%–70% with 
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specific Young’s moduli between 3.5–4.2 GPa was obtained for porous titanium fabricated by titanium 
fibre sintering, a potential candidate for cancellous bone substitution [8]. 
Several manufacturing methods have clearly demonstrated their abilities in achieving porosities and 
mechanical properties close to that of native bone, however, despite their achievement they are limited 
to a range of pore sizes and porosities and to their control over the final structure [6–8]. Advanced 
additive manufacturing techniques offers the precision and control over pore size and distribution, 
surface area and micro-architecture that cannot be matched by other manufacturing methods [20–25]. 
Advanced additive manufacturing techniques, such as electron beam melting (EBM), can therefore 
produce highly porous metallic structures with precisely controlled micro-architectures. With such a 
controlled method, structures can be fabricated to consist of varying porous micro-architectures allowing 
manipulation over the distribution of mechanical properties throughout the implant subsequently 
controlling the load bearing distribution throughout the structure. Furthermore, with advanced additive 
manufacturing the highest levels of porosity can be achieved further increasing space for more bone 
ingrowth [9,10] or surface area for drug delivery media [11]. 
Although high porosity, ideal mechanical properties and structure can be obtained through advanced 
additive manufacturing techniques, porous titanium structures must also be bio-functionalized to aid 
bone growth and integration. Several surface treatments such as plasma spray [26], gelatin [27], 
anodization [28] and chemical [28–30] treatments have been applied to porous titanium to improve its 
bio-functionality. Chemical surface treatments in particular have been successful in transforming 
titanium and titanium alloy surfaces from biologically inert to bio-functionalizing surfaces and are 
desirable due to their ease of application and low cost [28–31]. More specifically, alkali-acid-heat 
(AlAcH) treatment is a promising candidate among chemical treatments as it has been shown to 
effectively bio-functionalize the surface of porous titanium by creating nano-topographical features and 
modifying the surface chemistry of the structure [28,31] while maintaining adequate mechanical 
properties [32]. Since the surface properties of porous titanium are highly dependent on manufacturing 
technique, the effects of AlAcH treatment differs for each case, however, Takemoto et al. [31], 
successfully demonstrated promising morphology, apatite formation and bone regeneration for porous 
titanium fabricated by plasma spray. Amin Yavari et al. [28] showed similar results for porous titanium 
fabricated by selective laser melting (SLM).  
The current work evaluates the use of AlAcH treatment to bio-functionalize the surface of porous 
titanium alloy Ti-6Al-4V fabricated by EBM by examining its apatite forming ability. Various molar 
concentrations (3, 5, 10M) and immersion times (6, 24 h) of the alkali treatment were used for the AlAcH 
treatment to determine optimal parameters. Following AlAcH treatment, the apatite forming ability of 
the samples were evaluated using simulated body fluid (SBF) immersion testing. The micro-topography 
and surface chemistry of AlAcH treated porous titanium samples were examined before and after immersion 
in SBF using scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS).  
2. Results and Discussion 
In the current work, porous titanium fabricated by EBM was AlAcH treated to produce  
nano-topographical features and a crystalline titania layer to stimulate the formation of Ca and P, with a 
final objective of improving apatite forming ability. As shown in previous studies, the formation of  
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nano-topographical features [33–35] and the formation of crystalline titania [28,31] helps stimulate the 
formation of Ca and P, apatite and bone. 
2.1. AlAcH Treatment 
SEM analysis of the AlAcH treated samples revealed modified surfaces with irregular  
nano-topographical features ranging between 200 and 300 nm in size as compared to the smooth and 
featureless AsM surfaces (Figure 1 vs. Figure 2). The same topographical transformation was observed 
for all alkali molar concentrations and immersion times, however, those samples treated with stronger 
molar concentrations had increased nano-topographical features per unit area. Previous studies have 
shown that the presence of nano-topographical features helps promote the initial formation of Ca and P, 
and later apatite or bone [33–35]. The natural human extracellular matrix is a complex network made up 
of a collection of nanoscale structures and features and hence is stimulated and interacts with cells on a 
nanoscale level [36–38]. For bone, the use of artificial nanostructures allows intimate interactions with 
the first level of bone structural hierarchy allowing repopulation and re-synthesis of a new matrix for 
bone. Based on this understanding of the significance of nano-features, the current results suggest that 
an AlAcH treatment with higher molar concentration is ideal as stronger molar concentrations of NaOH 
resulted in increased nano-topographical features per unit area. This may theoretically provide more 
opportunity for interaction between the implant surface and cells.  
 
Figure 1. (a) Macrograph of test sample and (b) SEM micrograph of AsM surface. 
 
Figure 2. Cont. 
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Figure 2. SEM micrographs of samples after AlAcH treatment for various alkali parameters 
(a) 3M, 6 h (b) 3M, 24 h (c) 5M, 6 h (d) 5M, 24 h (e) 10M, 6 h and (f) 10M, 24 h. 
During the chemical treatment, immersion in NaOH alkali solution introduces a sodium titanate layer, 
the sodium is then removed by HCl acid leaving behind a layer of amorphous titania [31]. The heat 
treatment then transforms the titania from amorphous to crystalline (anatase and rutile), encouraging the 
formation of apatite because of its favorable atomic arrangement. Following AlAcH treatment, EDS 
elemental analysis confirmed a modified surface chemistry composed predominantly of oxygen and 
titanium as compared to the AsM samples composed primarily of titanium alone (Table 1 vs. Table 2). 
This was expected as the formation of crystalline titania is the culminating result of the AlAcH  
treatment [31]. Similar surface chemistry was observed for all AlAcH treated samples exposed to various 
alkali molar concentrations and immersion times, however, in general those exposed to higher 
concentrations and/or longer immersion times had increased oxygen content suggesting a more 
prominent titania layer (Table 2). This can be explained by the samples’ exposure to increased 
concentrations and/or immersion times of NaOH allowing more sodium titanate to form which 
eventually forms the final crystalline titania layer [31]. The increased amount of oxygen observed for 
the 3M, 6 h sample is assumed to be an outlier based on the trend of increased oxygen content with 
increased concentration and/or immersion time observed for all other samples. The increase in oxygen 
is assumed to represent the local area analyzed rather than the entire sample. The EDS elemental analyses 
therefore suggests that AlAcH treatment with a stronger molar concentration and/or longer immersion 
time alkali treatment may result in the formation of a more prominent titania layer. The phase of the 
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titania layer cannot be confirmed to be crystalline using EDS however, based on the results presented by 
Takemoto et al. [31] the culminating result of AlAcH treatment is expected to be a crystalline titania layer. 
Table 1. Chemical composition of the Ti-6Al-4V pre-alloyed powder used in electron beam 
melting and required by DIN EN ISO 5382-3 standards. 
Chemical Element Al V Fe O N H C Y Ti 
Used wt.% 6.4 4.1 0.21 0.13 0.01 0.004 0.01 <0.001 Balance 
Required wt.% 5.5–6.75 3.5–4.5 <0.3 <0.2 <0.05 <0.015 <0.08 -- Balance 
Table 2. EDS elemental analysis (wt. %) of AlAcH treated samples for various alkali 
concentrations and immersion times. 
Alkali treatment conditions O Al Ti V 
3M, 6 h 48.89 ± 0.51 2.15 ± 0.14 47.04 ± 0.22 1.91 ± 0.33 
5M, 6 h 18.83 ± 1.46 3.88 ± 0.21 74.74 ± 1.72 2.55 ± 0.80 
10M, 6 h 23.20 ± 5.35 3.46 ± 0.28 70.88 ± 5.62 2.45 ± 0.15 
3M, 24 h 25.66 ± 3.20 4.16 ± 0.17 67.79 ± 3.33 2.38 ± 0.82 
5M, 24 h 26.33 ± 2.85 3.30 ± 0.19 68.11 ± 2.90 2.26 ± 0.28 
10M, 24 h 28.05 ± 2.48 2.77 ± 0.28 67.58 ± 2.58 1.59 ± 0.04 
In conclusion, both SEM and EDS elemental analyses conducted following AlAcH treatment suggest 
that samples exposed to stronger molar concentration alkali treatment may produce more promising 
results for apatite forming ability. 
2.2. Apatite Forming Ability 
The purpose of chemically treating the porous titanium was to modify its surface topography and 
chemistry such that its apatite forming ability is improved. The apatite forming ability was tested by 
immersing AlAcH treated porous titanium samples in SBF for 1 and 3 weeks. After 1 and 3 week 
immersion in SBF, SEM observations and trends in the EDS results were similar therefore to eliminate 
redundancy the results following 3 week immersion in SBF are presented and discussed. SEM analysis 
confirmed that following 3 weeks of SBF immersion all surface topographies were generally unchanged, 
however, there were a limited number of surface structures that formed on AlAcH treated samples that 
were distinct to the surrounding topography (Figure 3b,d–f). As previously noted, an increase in  
nano-topographical feature density was observed with increasing alkali molar concentration and/or 
immersion time. AsM surfaces remained smooth and featureless after 3 weeks of SBF immersion  
(Figure 3a). Cross-sections revealed the depth of the nano-features observed on all EBM specimens after 
surface treatments (Figure 4). In all cases, the depth of the nano-features were in the sub-micron range, 
measuring a few hundred nanometers in size. 
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Figure 3. SEM micrographs after 3 week SBF immersion for (a) AsM and AlAcH treated 
samples for alkali treatment (b) 3M, 6 h (c) 3M, 24 h (d) 5M, 6 h (e) 5M, 24 h (f) 10M, 6 h 
and (g) 10M, 24 h. 
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Figure 4. SEM micrograph of cross-sectioned 3M, 6 h AlAcH treated sample at (a) 2kX and (b) 20kX. 
EDS elemental analysis confirmed that the AlAcH treatment was successful in improving Ca and P 
formation after 3 weeks of immersion in SBF however, no apatite was observed. Although the Ca and P 
was limited in terms of concentration and in distribution among the surface, both elements were present 
on all AlAcH treated samples except for those exposed to 3M, 6 h alkali treatment (Table 3). It is 
assumed that with an alkali treatment of 3M, 6 h the concentration and duration of the alkali treatment 
were inadequate in forming a substantial sodium titanate layer. Although the samples exposed to 3M,  
6 h alkali treatment formed nano-topographical features, the concentration and limited time may have 
contributed to a lack of a sodium titanate layer and subsequently a lack of Ca formation. Wei et al. [39] 
immersed microarc oxidized TiO2-based films in SBF following 1, 3 and 5M alkali treatment and 
concluded that apatite formation increased with increasing concentration of NaOH. They reported that 
the apatite XRD pattern for samples exposed to 3M NaOH for 24 h was very weak while demonstrating 
strong patterns for 5M alkali treatment. In a similar apatite formation study, Liang et al. [40] found that 
porous titanium fabricated by powder metallurgy exposed to 0.5 or 1M alkali solution had no apatite 
formation however apatite was observed for those exposed to 5 or 10M alkali solution following SBF testing. 
Table 3. EDS elemental analysis (wt. %) after 3 week SBF immersion for AsM and AlAcH 
treated samples with various alkali concentrations and immersion times. 
Element AsM 3M, 6 h 3M, 24 h 5M, 6 h 5M, 24 h 10M, 6 h 10M, 24 h 
N -- 9.78 ± 2.91 12.08 ± 7.00 6.15 ± 0.40 0.34 ± 0.59 2.8 ± 2.04 1.20 ± 1.05 
O -- 39.80 ± 7.94 31.16 ± 13.84 36.58 ± 9.97 20.07 ± 6.95 21.33 ± 10.92 24.59 ± 8.85 
Na -- -- 0.25 ± 0.13 1.11 ± 0.72 3.30 ± 0.62 0.65 ± 0.85 0.12 ± 0.20 
Mg -- -- -- 0.01 ± 0.02 0.02 ± 0.03 -- -- 
Al 4.97 ± 1.83 2.52 ± 0.59 3.08 ± 1.48 2.42 ± 0.07 3.52 ± 0.19 0.73 ± 0.31 0.64 ± 0.11 
Si -- 0.03 ± 0.06 0.02 ± 0.03 0.02 ± 0.04 -- -- 0.03 ± 0.06 
P -- 0.10 ± 0.11 0.20 ± 0.07 0.31 ± 0.01 0.24 ± 0.08 0.29 ± 0.10 0.37 ± 0.23 
Cl -- -- -- 0.74 ± 0.13 2.26 ± 0.39 0.11 ± 0.19 -- 
Ca -- -- 0.13 ± 0.12 0.37 ± 0.01 0.21 ± 0.03 0.15 ± 0.15 0.96 ± 0.13 
Ti 90.95 ± 2.22 40.54 ± 10.87 50.97 ± 18.32 50.97 ± 9.63 66.62 ± 7.51 70.28 ± 12.24 69.37 ± 8.39 
V 4.08 ± 0.40 1.55 ± 0.56 1.52 ± 0.54 0.69 ± 1.20 2.10 ± 0.07 2.19 ± 0.71 2.58 ± 0.44 
Fe -- 5.49 ± 5.76 0.58 ± 0.14 0.61 ± 0.07 1.32 ± 0.23 1.34 ± 0.31 0.16 ± 0.27 
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In addition, no Ca or P was detected on AsM surfaces following SBF immersion suggesting that the 
AlAcH treatment does to a degree encourage the formation of both Ca and P as both elements were 
present on almost all AlAcH treated samples. While there was no distinct pattern in the amount of Ca 
present based on the molar concentration and/or immersion time of the alkali treatment, wt. % of P was 
observed to generally increase with increasing molar concentration and immersion time. The greatest 
amount of Ca and P was observed for samples exposed to 10M, 24 h alkali treatment which coincides with 
the greatest density of nano-topographical features and presumably the most prominent titania layer.  
The results presented suggest that applying AlAcH treatment does promote Ca and P formation, 
however, they are preliminary as no apatite formation was visually observed. Nucleation and 
crystallization of apatite requires the mineral saturation state to be above the equilibrium state, allowing 
the mineral to precipitate from solution [41–43]. Variations in the supersaturated solution caused by 
circumstances such as an imbalance in SBF reagent concentrations or contamination may hinder 
nucleation, potentially explaining the lack of apatite formation [44]. Additional parameters of the AlAcH 
treatment applied should also be adjusted to further optimize the parameters for apatite formation on 
porous titanium specifically fabricated by EBM. Various other chemical surface treatment studies have 
shown the apatite forming ability greatly depends on the parameters chosen. For example, while studying 
alkali-heat surface treatments Uchida et al. [45] found that the temperature and immersion time of the 
water treatment following immersion in NaOH affects the amount of apatite formed. The greatest amount 
of crystalline titania formed, which they found correlated well with the amount of apatite formation, 
occurred for the highest temperature and longest immersion time in water (80 °C, 48 h). In a similar 
study by Kim et al. [46], varying the heat treatment temperature following the chemical treatment also 
affected the apatite forming ability. The heat treatment temperature and duration are significant; it needs 
to be high and long enough to stabilize the oxide layer but not too high or long as it alters the ratio of 
anatase/rutile crystalline titania phases which regulate the rate of apatite formation. 
Different bioactivity pathways, namely, chemical and biological pathways, should also be considered 
in analyzing the results [47]. In vitro SBF tests rely on the stimulation of chemical pathways, forming 
bonds and compounds that stimulate the formation of apatite, and eventually bone regeneration. In vitro 
cell culture tests also provide chemical pathways as well as bioactivity pathways for bone regeneration 
through interactions between surface biomolecules and cellular pathways. In some cases the results of 
SBF and cell culture tests disagree [48], presumably due to differing bioactivity pathways. Amin Yavari 
et al. [28] demonstrated that SLM porous titanium exposed to acid-alkali treatment and porous titanium 
exposed to an anodizing heat treatment exhibited bioactivity through different pathways. Samples 
exposed to acid-alkali treatment had the highest apatite forming ability after SBF immersion but 
performed poorly in cell culture assays with limited cell attachment and proliferation. In contrast, 
samples exposed to anodizing heat treatment had high levels of cell attachment and proliferation but 
almost no apatite formation. While their results justify our choice in using SBF as a means of evaluating 
biofunctionality, the biological bioactivity pathways of differing advanced additive manufacturing 
techniques, namely SLM and EBM, may differ potentially explaining the lack of apatite formation observed. 
The current work does have its limitations. The study is confined in that only the molar concentration 
and immersion time of the alkali treatment were varied, however, various other parameters such as the 
temperature, concentration and immersion time of water and acid treatment as well as the temperature 
and duration of heat treatment should be considered to find ideal parameters for apatite formation.  
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Also, SEM/EDS elemental analysis is limited in characterizing the surface of porous titanium and should 
only be used for preliminary detection of apatite by visual indication and Ca and P formation; following 
studies should use X-ray diffraction to detect apatite phase.  
3. Experimental Section 
3.1. Materials and Manufacturing 
EBM techniques (implantcast GmbH, Germany) were employed to produce porous titanium samples 
from Ti6Al4V alloy powder based on DIN EN ISO 5832-3 standards (Table 1) [49]. The samples were 
produced on a Q10 machine (Arcam AB, Sweden) in a controlled high vacuum chamber kept at 3 × 10E-6 
bar using helium gas intake. The porous structures (EPORE®) designed and manufactured by implantcast 
were based on a random structure designed to meet the properties of cancellous bone with strut size of 
360 µm, porosity of 60% and specific Young’s Modulus of 3.1 GPa. The samples were discs with an 
outer diameter of 8 mm, a height of 3 mm and a concentric hole with a diameter of 2 mm. 
3.2. Surface Treatment  
Prior to surface treatment, all samples were ultrasonically cleaned using ethanol followed by ultrapure 
water for 10 min each, then were dried in an oven overnight at 40 °C. The samples were then immersed 
in either 3, 5 or 10M NaOH at 60 °C for either 6 or 24 h as shown in Table 4. 
Table 4. Alkali treatment parameters tested during AlAcH treatment. 
Group name 3M, 6 h 3M, 24 h 5M, 6 h 5M, 24 h 10M, 6 h 10M, 24 h 
Molar concentration NaOH (M) 3 3 5 5 10 10 
Immersion time (hrs) 6 24 6 24 6 24 
After the alkali treatment, the samples were immersed in ultrapure water at 40 °C for 24 h then in  
0.5 mM HCl at 40 °C for 24 h. After the acid treatment, the samples were washed with ultrapure water 
and dried in an oven at 40 °C for 24 h before they were placed in the furnace at 600 °C for  
1 h dwelling time. The heating rate of the furnace was 5 °C/min. The samples were allowed to cool down 
in the furnace. An SEM JEOL (JSM-6500F, Japan) coupled with an EDS was used for observing the 
surface and conducting elemental analysis. The EDS spectra were taken at an accelerating voltage of  
10 kV and a magnification of 12kX. 
3.3. Apatite Forming Ability 
All surface treated samples, along with as manufactured (AsM) samples were immersed in SBF to 
evaluate their apatite forming ability. The SBF solution was prepared based on NEN-ISO 23317 
standards for in vitro evaluation for apatite-forming ability of implant materials [50]. 8.035 g NaCl, 
0.355 g NaHCO3, 0.225 g KCl, 0.231 g K2HPO4.3H2O, 0.311 g MgCl2.6H2O, 39 mL 1M HCl, 0.292 g 
CaCl2, 0.072 g Na2SO4 and 6.118 g Tris were added sequentially to 700 mL of deionized water at 37 °C. 
After dissolving all reagents the pH of the solution was adjusted to 7.4 by incrementally adding 1M HCl. 
Deionized water was then added to the solution to reach a volume of 1 L. 
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The samples were individually immersed in 15 mL fresh SBF at 37 °C using 50 mL plastic tubes as 
described by the standards [46]. The plastic tubes were then placed in a water bath maintained at 37 °C. 
The samples were removed from the water bath after 1 and 3 weeks, washed with deionized water and 
dried overnight at 40 °C. An SEM JEOL (JSM-6500F, Japan) coupled with an EDS was used for 
observing the surface and conducting elemental analysis. The EDS spectra were taken at an accelerating 
voltage of 10 kV and a magnification of 12kX. To further characterize the surface topography the cross 
section of samples were also immersed in nitrogen, cross-sectioned and examined by SEM. 
4. Conclusions 
AlAcH treatment successfully modified the topographical and chemical characteristics of EBM 
porous titanium surface. The chemical and heat treatment created a surface with nano-topographical 
features ranging in the size of 200–300 nm with a titania layer ideal for apatite formation. After  
3 weeks immersion in SBF there was no Ca or P present on the surface of AsM porous titanium, however, 
both elements were present on all AlAcH treated samples except those exposed to 3M, 6 h alkali 
treatment. An increase in alkali solution concentration resulted in an increase in the number of  
nano-topographical features per unit area as well as the amount of titania on the surface. The greatest 
amount of Ca and P was observed for samples exposed to 10M, 24 h alkali treatment which coincides 
with the greatest density of nano-topographical features and presumably the most prominent titania layer. 
Although no apatite was visually observed, the presence of Ca and P does indicate that AlAcH treatment 
does encourage the formation of both elements as AsM surfaces contained neither. Future studies should 
focus on optimizing additional parameters in the AlAcH treatment to achieve ideal surface conditions 
for apatite formation. 
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